{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:25:12Z","timestamp":1787217912446,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjms.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:31:50Z","timestamp":1781278310000},"page":"276-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraductal papillary mucinous neoplasm worsening glycemic control in a patient with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"372","author":[{"given":"Ron T.","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur D.","family":"Ayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana R.","family":"Zamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feranmi K.","family":"Oyalade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana C.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie L.","family":"Aoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2026.06.011_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1055-9965.EPI-22-0951","article-title":"The relationship between diabetes mellitus and pancreatic cancer-diabetes mellitus as a red flag for pancreatic cancer","volume":"32","author":"Popovic","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.amjms.2026.06.011_bib0002","article-title":"Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2026.06.011_bib0003","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2026","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjms.2026.06.011_bib0004","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer","author":"Pereira","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2026.06.011_bib0005","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1007\/s00125-025-06543-y","article-title":"Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis","author":"Toledo","year":"2025","journal-title":"Diabetologia"},{"issue":"10471","key":"10.1016\/j.amjms.2026.06.011_bib0006","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(24)02187-1","article-title":"Chroninc pancreatitis","volume":"404","author":"Thierens","year":"2025","journal-title":"Lancet"},{"issue":"Supplement_1","key":"10.1016\/j.amjms.2026.06.011_bib0007","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: Standards of Care in diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.amjms.2026.06.011_bib0008","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 Diabetes, 2022. A consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.amjms.2026.06.011_bib0009","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.amjms.2026.06.011_bib0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.9738\/INTSURG-D-14-00220.1","article-title":"Intraductal papillary mucinous neoplasm of the pancreas: current perspectives","volume":"100","author":"Dumlu","year":"2015","journal-title":"Int Surg"},{"key":"10.1016\/j.amjms.2026.06.011_bib0011","unstructured":"Whitcomb DC, ed. Intraductal papillary mucinous neoplasm of the pancreas (IPMN): evaluation and management. UpToDate. 2025."},{"issue":"10","key":"10.1016\/j.amjms.2026.06.011_bib0012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4240\/wjgs.v2.i10.359","article-title":"Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas","volume":"2","author":"Yopp","year":"2010","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.amjms.2026.06.011_bib0013","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.sla.0000124386.54496.15","article-title":"Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection","volume":"239","author":"Salvia","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.amjms.2026.06.011_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/2050640616684695","article-title":"United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)","volume":"5","author":"L\u00f6hr","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.011_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s002680020337","article-title":"Pancreatic resection: effects on glucose metabolism","volume":"25","author":"Slezak","year":"2001","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.amjms.2026.06.011_bib0016","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model","volume":"61","author":"Gier","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.amjms.2026.06.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50408","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes","volume":"7","author":"Dankner","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.amjms.2026.06.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50408","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes","volume":"7","author":"Dankner","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.amjms.2026.06.011_bib0019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.amjms.2026.06.011_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2026.06.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/00031348261443329","article-title":"Perioperative diabetic ketoacidosis in type 2 diabetes: risk and prevention in the era of SGLT2 inhibitors","author":"Kuo","year":"2026","journal-title":"Am Surg"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926002338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926002338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:41:48Z","timestamp":1787215308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926002338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0002962926002338"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.06.011","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraductal papillary mucinous neoplasm worsening glycemic control in a patient with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}